NGNE
Neurogene Inc
25.70$
-3.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.04 | -2.30 | -1.28 | -0.94 | -0.92 | -1.18 | -0.99 | -0.92 | -0.93 | -1.08 | -1.17 | -1.05 | -3.82 | |
| 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.15 | |
| 0.03 | 0.03 | 0.06 | 0.14 | 0.15 | 0.17 | 0.19 | 0.16 | 0.16 | 0.22 | 0.16 | 0.35 | 0.81 | |
| 0.15 | 0.10 | -0.40 | -0.07 | 0.15 | -0.06 | -0.07 | -0.02 | -0.06 | 0.22 | 0.05 | 0.10 | 0.24 | |
| 0.01 | 0.02 | 0.00 | 0.03 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | |
| -0.01 | 1.30 | 1.77 | -1.39 | -1.71 | -6.91 | -2.15 | 0.35 | 1.06 | 1.93 | 2.07 | 0.27 | 4.64 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | – | |
| – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.17 | 7.17 | -0.39 | 0.02 | 0.01 | 12.79 | 0.00 | 0.00 | 0.47 | 1.33 | 0.01 | 0.27 | 1.62 | |
| -1.21 | 9.59 | 0.10 | -2.31 | -2.62 | 4.71 | -3.13 | -0.57 | 0.58 | 2.12 | 0.91 | -0.52 | 2.38 | |
| -1.05 | -2.28 | -1.28 | -0.97 | -0.93 | -1.19 | -1.03 | -0.93 | -0.94 | -1.08 | -1.18 | -1.07 | -3.86 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.